Furthermore, a systematic review and meta-analysis suggested that the IL-6 receptor pathway might be a causal signaling in human AAA pathogenesis and inhibition of IL-6R may contribute to AAA treatment (Harrison et al., 2013). This evidence concerns the gene IL6R and triple-A syndrome.